Aaron Rosenberg, Chief Financial Officer at BeOne Medicines Ltd. (ONC), sold 631 shares at $257.74 ($163K) on 2026-06-11, disclosed to the SEC on 2026-06-15.
Open-market sale of $163k ONC by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |